Salesforce (CRM, $216.05) beats Q2 earnings; raises full-year revenue outlook

Salesforce  posted second second-quarter earnings that exceeded analysts’ expectations. The cloud company also boosted its full-year revenue guidance.

For the three months ending July, the company’s non-GAAP diluted earnings came in at $1.44 a share, compared to the  67 cents a share expected by analysts polled by FactSet.

Revenue increased +29% year-over-year to $5.15 billion, also beating analyst’ estimate of $4.9 billion.

"It's humbling to have had one of the best quarters in Salesforce's history against the backdrop of multiple crises seriously affecting our communities around the world," said Salesforce Chief Executive Marc Benioff.

For the current quarter, Salesforce expects sales to range between $5.24 billion and $5.25 billion.

Looking further ahead, the company raised guidance to between $20.7 billion and $20.8 billion (up 21% to 22% year over year) for the full fiscal 2021, compared to its prior guidance of  $20 billion.

Tickeron's AI-powered analysis rates CRM a Strong Buy.

According to Tickeron, CRM enters an Uptrend because Momentum Indicator exceeded the 0 level on August 18, 2020

This indicator signals that CRM's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the ticker or exploring call options. In 58 of 79 cases where CRM's Momentum Indicator exceeded 0, its price rose further within the subsequent month. The odds of a continued Uptrend are 73%.

Current price $216.05 is above $198.88 the highest resistance line found by A.I. Throughout the month of 07/23/20 - 08/24/20, the price experienced a +11% Uptrend. During the week of 08/17/20 - 08/24/20, the stock enjoyed a +6% Uptrend growth.

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) just turned positive. Considering data from situations where CRM's MACD histogram became positive, in 33 of 49 cases, the price rose further within the following month. The odds of a continued Uptrend are 67%.

The Aroon Indicator entered an Uptrend today. In 226 of 347 similar cases where CRM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.

Bearish Trend Analysis

The RSI Indicator appears to be shifting from an Uptrend to a Downtrend. In 22 of 44 cases where CRM's RSI indicator exited the overbought zone, the price fell further within the following month. The odds of a continued Downtrend are 50%.

The Stochastic Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The higher Bollinger Band was broken -- a price fall is expected as the ticker heads toward the middle band, which invites the trader to consider selling or shorting the ticker, or exploring put options. In 23 of 40 cases where CRM's price broke its higher Bollinger Band, its price dropped further during the following month. The odds of a continued Downtrend are 57%.

Fundamental Analysis (Ratings)

Tickeron has a positive outlook on this ticker and predicts a further increase by more than 4.00% within the next month with a likelihood of 79%. During the last month, the daily ratio of advancing to declining volumes was 2.64 to 1.

The Tickeron PE Growth Rating for this company is 3 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 12 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 14 (best 1 - 100 worst), indicating outstanding price growth. CRM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 49 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.42) is normal, around the industry mean (8.03). P/E Ratio (864.19) is within average values for comparable stocks, (310.07). Projected Growth (PEG Ratio) (6.49) is also within normal values, averaging (7.24). Dividend Yield (0.00) settles around the average of (0.34) among similar stocks. P/S Ratio (8.11) is also within normal values, averaging (14.81).